IP Verse

Kivial competitive analysis

Explore patent oppositions filed by Kivial against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026

Patent Number	Title	Applicant	Opposition Date
EP4364724	High Concentration Vegf Receptor Fusion Protein Containing Formulations	REGENERON PHARMACEUTICALS	Aug 26, 2026
EP4185318	Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye Disorders	BAYER HEALTHCARE	Jun 3, 2026
EP3730126	Liquid Composition Comprising Vegf Antagonist	SAMSUNG BIOEPIS	Feb 13, 2026
EP3241561	Chimeric Antigen Receptor (Car) With Antigen Binding Domains To The T Cell Receptor Beta Constant Region	AUTOLUS	Jan 30, 2026
EP3199033	Natural High-Potency Sweetener Compositions With Improved Temporal Profile And/Or Flavor Profile, Methods For Their Formulation, And Uses	THE COCA COLA	Jul 7, 2021
EP2213034	Improved Ack/Nack Dtx Detection And Signalling Of Not Receiving A Downlink Allocation Grant Message	NOKIA SIEMENS NETWORKS	May 26, 2015
EP2286629	Method And Apparatus To Link Modulating And Coding Scheme To Amount Of Resources	NOKIA SIEMENS NETWORKS	May 13, 2015

Discover the latest PTAB cases involving Kivial, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Kivial with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
KIVIAL	7	-	-	-
NOKIA SIEMENS NETWORKS	-	9	-	-
NOKIA SOLUTIONS AND NETWORKS	10	26	12	10
REGENERON PHARMACEUTICALS	55	153	9	32